Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Medtech 360 | Market Analysis | China | 2016

The recent economic downturn in China will have only limited impact on the Chinese market for IC devices, which will experience robust growth through 2024, driven primarily by the rising prevalence of CAD among the Chinese population and the introduction of more advanced diagnostic and treatment technology.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in China across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…
Report
Interventional Cardiology Devices – Market Insights – Middle East (Supplemental)
The MESA IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive…
Report
Interventional Cardiology Devices | Market Insights | Latin America (Supplemental) | 2025
The Latin American IC device market has recovered from the COVID-19 pandemic and is reverting to prepandemic growth trends. Increasing patient pool, launch of newer generation devices and…
Report
Interventional Cardiology Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally…